CIK: 816284 - Address: 86 Morris Avenue, Summit, NJ 07901
16 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret3197813-1-22-0
P%wins89565650631755

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/6/20 17:24
7/1/20
XLRNAcceleron Pharma IncDEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP10,00092.50010826,972D
11/14/19 16:06
11/12/19
AGIOAgios Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP12,50031.00040367,122D
1/22/19 17:00
1/18/19
XLRNAcceleron Pharma IncDEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP30,36743.000706126,825D
1/31/18 08:39
1/23/18
AGIOAgios Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP.a57,02767.000851156,718D
1/23/18 16:35
1/23/18
AGIOAgios Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP57,02767.000851156,718D
9/25/17 16:23
9/25/17
XLRNAcceleron Pharma IncDEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP27,58737.000746146,118D
3/1/17 16:19
2/27/17
ALQAAlliqua Biomedical, Inc.DEHealthMdEqSurgical & Medical InstrumentCelgene Corp /de/NJTP2,0000.500004,0001317,046D-91-51-51-31-21-11-242847-24
10/27/16 16:45
10/24/16
CRSPCrispr Therapeutics AGDEHealthBioPrdBiological Products, (No DiagCelgene Corp /de/NJTP.ad11,20214.006800204,835I76-331188
10/26/16 16:15
10/24/16
CRSPCrispr Therapeutics AGDEHealthBioPrdBiological Products, (No DiagCelgene Corp /de/NJTP.d11,20214.007800204,835D3722312615
1/11/16 16:17
1/11/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagCelgene Corp /de/NJTP32,00040.0022800175,373D-17-161542-19-22-31-143-1-27-101-21
5/4/15 16:19
5/4/15
ALQAAlliqua Biomedical, Inc.DEHealthMdEqSurgical & Medical InstrumentCelgene Corp /de/NJTP3,0004.551659283,046D57-3017-4-9-1-2-2-2-565-36-81
5/6/14 16:01
5/5/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagCelgene Corp /de/NJTP47,14642.86131,100324,573D48-25-13-105-354-4-417-12
4/15/14 16:01
4/14/14
ALQAAlliqua, Inc.FLHealthMdEqSurgical & Medical InstrumentCelgene Corp /de/NJTP.d5,0007.000714432,387D15994122-22-26-20-20-1317170-22-32-25
1/29/14 17:18
1/28/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagCelgene Corp /de/NJTP15,00050.001430093,473D10762140-70-11-5-34-44-22
9/26/13 16:16
9/24/13
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagCelgene Corp /de/NJTP.d10,00015.0028667273,173D8365476329
10/18/10 18:50
10/15/10
ABIIAbraxis Bioscience, Inc.DEHealthDrugPharmaceutical PreparationsCelgene Corp /de/NJTP00.00040,7350D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact